+ Phase-III-support-Biomarkers

Biomarkers

Expert scientific expertise to evaluate and select the most appropriate marker for your study

At Sequani we recognise the growing interest in applying specific biomarkers to the pre-clinical evaluation of novel drug candidates, both during discovery/lead optimisation and safety assessment.  Our biomarkers team was set up in response to this industry trend and includes two leading scientists in the field.